---
title: "Beyond the AI Hype: Practical Applications to Augment Medication Management Decisions - Part 2"
description: Get insights about three critical areas where artificial intelligence (AI) technology is transforming medication management. Part 2 of our AI blog series.
image: https://blog.pocp.com/hubfs/Imported_Blog_Media/iStock-645606376-400x278-1.jpg
---
[](https://www.pocp.com/)
# Accelerating client's success
# using Health IT and
# business process solutions...
[Learn More](https://www.pocp.com/the-pocp-story/)
# Simplifying
# regulatory
## compliance...
[Learn More](https://www.pocp.com/regulatory-resource-center/)
# Creating value in today's
# healthcare ecosystem...
[Learn More](https://www.pocp.com/our-client/)
- Consulting
- [Strategy & Market Intelligence](https://www.pocp.com/strategy-market-intelligence/)
- [Education & Research](https://www.pocp.com/education-research/)
- [Value-Based Care Interoperability Roadmap](https://info.pocp.com/en-us/value-based-care-interoperability-strategy-and-roadmap)
- [Multi-stakeholder Collaboratives, Program Design and Management](https://www.pocp.com/multi-stakeholder-initiatives_program-design_management)
- [EHR Training Programs](https://www.pocp.com/ehr-training-programs/)
- [Life Sciences](https://www.pocp.com/life-sciences)
- [Regulatory Resource Center](https://www.pocp.com/regulatory-resource-center)
- About Us
- [The POCP Story](https://www.pocp.com/the-pocp-story/)
- [Our Clients](https://www.pocp.com/our-client/)
- [Health & IT Vendors](https://www.pocp.com/our-client/health-it-vendors/)
- [Payers & PBMS](https://www.pocp.com/our-client/payers-pbms/)
- [Accountable Care](https://www.pocp.com/our-client/accountable-care/)
- [Health Information Exchange](https://www.pocp.com/resource-library/health-information-exchange/)
- [Our Team](https://www.pocp.com/our-team/)
- [Government Contracting](https://info.pocp.com/gsa)
- [Press](https://www.pocp.com/press/)
- [Calendar](https://info.pocp.com/en-us/events)
- [Careers at POCP](https://www.pocp.com/the-pocp-story/careers-at-pocp/)
- Insights
- [Articles and Industry Comments](https://www.pocp.com/articles/)
- [Blog](https://blog.pocp.com/blog/)
- [Newsletters HIT Perspectives](https://www.pocp.com/insight/newsletters-2/)
- [Newsletters Biopharma](https://www.pocp.com/newsletters-biopharma/)
- [POCP Industry Reports](https://www.pocp.com/industry-reports)
- [POCP Industry Reports](https://www.pocp.com/industry-reports)
- [ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy](https://www.pocp.com/downloads/ePAReport)
- [Real-Time Pharmacy Benefit Check Report](https://www.pocp.com/pocp-industry-reports/real-time-pharmacy-benefit-check-report/)
- [Fighting the Opioid Epidemic at the State- and Rx-Level Report](https://www.pocp.com/downloads/fighting-opioid-epidemic-at-rx-level-report)
- [ePrescribing State Law On-Demand](https://www.pocp.com/downloads/eprescribing-state-law-on-demand/)
- [State Law Review](https://www.pocp.com/statelawreview/)
- [Navigator](https://www.pocp.com/navigator/)
- [Podcasts](https://info.pocp.com/en-us/the-dish-on-health-it-podcast)
- [Presentations and Webinars](https://www.pocp.com/presentations/)
- [Resource Library](https://www.pocp.com/resource-library/)
- [White Papers, Webinars and Case Studies](https://www.pocp.com/white-papers-webinars-and-case-studies-2/)
- [Our video channel](https://www.pocp.com/our-video-channel)
- [Contact](https://www.pocp.com/contact/)
- Consulting
- [Strategy & Market Intelligence](https://www.pocp.com/strategy-market-intelligence/)
- [Education & Research](https://www.pocp.com/education-research/)
- [Value-Based Care Interoperability Roadmap](https://info.pocp.com/en-us/value-based-care-interoperability-strategy-and-roadmap)
- [Multi-stakeholder Collaboratives, Program Design and Management](https://www.pocp.com/multi-stakeholder-initiatives_program-design_management)
- [EHR Training Programs](https://www.pocp.com/ehr-training-programs/)
- [Life Sciences](https://www.pocp.com/life-sciences)
- [Regulatory Resource Center](https://www.pocp.com/regulatory-resource-center)
- About Us
- [The POCP Story](https://www.pocp.com/the-pocp-story/)
- [Our Clients](https://www.pocp.com/our-client/)
- [Health & IT Vendors](https://www.pocp.com/our-client/health-it-vendors/)
- [Payers & PBMS](https://www.pocp.com/our-client/payers-pbms/)
- [Accountable Care](https://www.pocp.com/our-client/accountable-care/)
- [Health Information Exchange](https://www.pocp.com/resource-library/health-information-exchange/)
- [Our Team](https://www.pocp.com/our-team/)
- [Government Contracting](https://info.pocp.com/gsa)
- [Press](https://www.pocp.com/press/)
- [Calendar](https://info.pocp.com/en-us/events)
- [Careers at POCP](https://www.pocp.com/the-pocp-story/careers-at-pocp/)
- Insights
- [Articles and Industry Comments](https://www.pocp.com/articles/)
- [Blog](https://blog.pocp.com/blog/)
- [Newsletters HIT Perspectives](https://www.pocp.com/insight/newsletters-2/)
- [Newsletters Biopharma](https://www.pocp.com/newsletters-biopharma/)
- [POCP Industry Reports](https://www.pocp.com/industry-reports)
- [POCP Industry Reports](https://www.pocp.com/industry-reports)
- [ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy](https://www.pocp.com/downloads/ePAReport)
- [Real-Time Pharmacy Benefit Check Report](https://www.pocp.com/pocp-industry-reports/real-time-pharmacy-benefit-check-report/)
- [Fighting the Opioid Epidemic at the State- and Rx-Level Report](https://www.pocp.com/downloads/fighting-opioid-epidemic-at-rx-level-report)
- [ePrescribing State Law On-Demand](https://www.pocp.com/downloads/eprescribing-state-law-on-demand/)
- [State Law Review](https://www.pocp.com/statelawreview/)
- [Navigator](https://www.pocp.com/navigator/)
- [Podcasts](https://info.pocp.com/en-us/the-dish-on-health-it-podcast)
- [Presentations and Webinars](https://www.pocp.com/presentations/)
- [Resource Library](https://www.pocp.com/resource-library/)
- [White Papers, Webinars and Case Studies](https://www.pocp.com/white-papers-webinars-and-case-studies-2/)
- [Our video channel](https://www.pocp.com/our-video-channel)
- [Contact](https://www.pocp.com/contact/)
# Insights: Brief Points of View
# POCP Blog
---
## Beyond the AI Hype: Practical Applications to Augment Medication Management Decisions - Part 2
- January 31, 2019
- By [Michael Solomon](https://blog.pocp.com/blog/author/michael_solomon)
- [2](https://blog.pocp.com/blog/beyond-the-ai-hype-part-2#comments-listing)
Share this story:
By [Michael Solomon](https://www.pocp.com/team/michael-r-solomon-phd-mba/), Ph.D., MBA
*This is the second of a three-part series on AI applications to support prescription drug prescribing and therapy*
 AI is a catalyst in many innovations being rolled out
Amidst the uncertainty of healthcare policy and ever-increasing cost pressures, [health system CEOs](https://www.modernhealthcare.com/article/20180519/NEWS/180519911) see the pace of innovation in their organizations speeding up, with improving the patient experience the area in greatest need of change. Many CEOs are investing in information technology (IT) to help make their organizations more [consumer-centric](https://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/us-lshc-deloitte-2017-survey-of-us-health-system-ceos.pdf), recognizing that consumer satisfaction and loyalty are critical to success in a value-based care environment.
A major area of focus is leveraging IT to make access to care easier and more convenient for consumers. Streamlining the steps involved to get onto therapy – and interact with providers during the course of treatment – cannot come soon enough for the [80 million+](https://www.cdc.gov/nchs/data/hus/2017/079.pdf) of people in the U.S. on multiple medications. The good news is that payers and providers are pouring money into technologies to improve the patient experience, and artificial intelligence is a catalyst in many innovations being rolled out.
In addition to the practical applications of AI technology to improve medication safety described in [part 1 of this series](https://www.pocp.com/real-applications-artificial-intelligence-in-medication-management/), machine-learning and natural language processing (NLP) are streamlining tasks that take place during the initial medication review process and ongoing therapy management.
Real world AI technology is transforming three areas with a reputation for falling short in giving patients high quality and timely care during the course of managing their often complex medication therapies:
- prior authorizations,
- monitoring medication adherence,
- and the scheduling of follow-up visits to assess therapy progress.
These tasks share three attributes that make them attractive candidates for the application of AI. They are repetitive in nature, require precise and medically appropriate actions based on a complex set of factors, and are labor-intensive. Let’s look at how machine learning and NLP are being applied to make these activities more reliable and efficient – and a better experience for consumers.
### **Streamlining Prior Authorizations**
“Usually back-office functions are highly inefficient and costly and measurable. There’s a clear ROI \[for AI\]” said Dr. William Morris, associate CMIO at Cleveland Clinic in a recent [in-depth article](http://www.modernhealthcare.com/indepth/Artificial-Intelligence-in-Healthcare-Makes-Slow-Impact/) on the potential of AI in healthcare. The administrative burden of drug prior authorization (PA) to providers is well-documented as is the [adverse impact](http://www.urologytimes.com/modern-medicine-feature-articles/prior-authorization-caught-administrative-nightmare) on patients needing therapy; calls for change have reached a [crescendo](https://www.ama-assn.org/press-center/press-releases/health-care-coalition-calls-prior-authorization-reform). The labor-intensive and error-prone processes of collecting the documentation required and subsequently adjudicating the PA request can be dramatically improved by using evidence-based algorithms and NLP.
Despite the growing use of electronic prior authorization (ePA), the submission and review of clinical documentation for drugs requiring approval – especially medication therapies involving specialty drugs – is plagued with duplicate data entry, delays, and rework. The required documentation is often located in the clinical notes narrative of the electronic health record (EHR). The required clinical data can be extracted and transformed into structured data using NLP. This information – along with other necessary data – forms the clinical documentation to send at the same time as the ePA request is submitted.
How does the ePA program know what data is required to send? This is where evidence-based algorithms and machine-learning come into play. With AI, the adjudication process is transformed. ePA becomes a decision support tool for the prescriber. The evidence-based algorithmic programs factor in the therapy policy and restrictions (including formulary), gather patient-specific data (e.g., the patient’s health status and medical history), and outcomes of patient populations with similar characteristics to present the prescriber with therapy recommendations. Selection of one of the recommendations triggers automatic approval of the PA request in real-time.
This “next generation” ePA will be prevalent in the not-too-distant future. eviCore (a subsidiary of Express Scripts) has implemented an AI engine that uses NLP to [extract data](https://www.healthcaredive.com/news/spotlight-AI-payers-doctors-artifical-intelligence/528424/) needed to adjudicate a PA. OptumLabs is working on increasing the level of auto-adjudication of PAs by [using algorithms](https://nam.edu/wp-content/uploads/2017/12/Bleicher-OL-Presentation-NAM-AI-for-Health-Care-11-30-17-Final.pdf) to predict which PAs should be approved. As a result, we’ll see more consistent and accurate PA adjudications, faster turnaround for patients to get onto therapy, and reduced administrative costs for both payers and providers.
### **Ongoing Therapy Management**
Filling the prescription and starting the therapy is just the beginning of a journey fraught with potential obstacles that could result in the patient not adhering to the prescribed regimen and ultimately needing expensive urgent or acute care. Fortunately, AI technology can be used to monitor patient adherence and notify clinicians when an intervention may be needed. The application of NLP and machine learning turns what would otherwise be a labor-intensive and cost-prohibitive activity into one where clinicians devote time only when needed.
[A recent survey](https://syneoshealthcommunications.com/uploads/articles/972/Syneos_Health_Communications_2018_Artificial_Intelligence_for_Authentic_Engagement.pdf) of patients with chronic conditions revealed that when it comes to health care, they are most comfortable with the use of AI in the form of “virtual assistants” helping them to manage their prescriptions and schedule follow-up appointments. This willingness opens the door for the use of AI technology to assist patients in staying on their therapy and conveniently getting the help they need when confronted with challenges.
### **Aiding patients in medication adherence**
Using predictive analytics, a [Medicare Advantage](https://www.inovalon.com/resources/me-medicare-case-study/) plan identifies those members at risk of non-adherence who would likely be more receptive to digital interventions (e.g., personalized text messages about refills, [remote patient monitoring](https://www.geneia.com/blog/2018/may/three-ways-to-use-predictive-analytics-to-identify-patients-best-suited-to-rpm)) rather than telephone calls or letters. By focusing on patients at greatest risk, and communicating in the most effective way, adherence rates are higher.
This strategy could be extended to predict specific difficulties a patient is likely to experience in adhering to a prescribed medication regimen and determine the most appropriate intervention (i.e. right level of intensity and approach for patient compliance, optimal effectiveness, and lowest cost). Drawing on the patient’s EHR (both structured and unstructured data) and patient interactions with a virtual assistant, multiple sets of factors can continuously be monitored by analytics that both predict risks of failure and prescribe actions. For example, factors such as the number of medications a patient must take, if different physicians are prescribing, whether a spouse or caretaker resides in the home, and the travel distance to the drug store can all be considered simultaneously when determining the need for and frequency of follow-up consultations.
Natural language processing coupled with machine learning is enabling the [98point6 virtual assistant](https://www.modernhealthcare.com/article/20181124/TRANSFORMATION01/181119931) to chat with a patient to understand the challenge or problem, ask follow-up questions, and forward the report to a clinician who diagnoses the problem and prescribes treatment. Most interventions do not require an in-person patient visit and are prescribed relatively quickly. A virtual assistant could be used to contact the patient, recommend switching to 90 day mail refill, or suggest a follow-up appointment.
### **Patient Appointments **
The scheduling of follow-up appointments with a patient’s doctor or pharmacist to assess a medication therapy’s progress often doesn’t happen because of the time it takes and inconvenience. Clinics in Quebec, Canada are reducing patient wait times with a scheduling application that uses machine learning to dynamically [predict expected wait times](https://www.healthdatamanagement.com/articles/ai-scours-12-million-appointments-to-cut-doc-office-wait-times?tag=00000157-0f79-d9a8-a5d7-ff7d1e2d0000) and send a text message to patients two hours before their scheduled appointments with updates on when they can be expected to be seen. This program uses machine learning to detect patterns in more than a million of past appointment wait times and based on hundreds of factors, including attributes of patients scheduled to be seen on a given day, the day of the week, and the doctor’s past performance on a given day.
Providence St. Joseph Health is taking AI-assisted scheduling a step further with its [No Show application](https://www.healthcareitnews.com/news/providence-st-joseph-finds-success-leveraging-ai-and-machine-learning-projects)}. No Show features a machine-learning model that predicts which patients are likely to be late for or cancel an appointment, and recommends an intervention based on the patient’s preferences and past responses.
In just a few short years, the application of machine learning and NLP will have a profound and positive impact on the relationship between consumers and their health care providers. Is AI the most exciting technology advancement in healthcare since electronic data interchange three decades ago?
Please e-mail me at [michael.solomon@pocp.com](mailto:michael.solomon@pocp.com)with your observations and/or questions. Use the comments at this POCP blog post to share your thoughts on the potential of AI to improve the patient experience as medications are prescribed and used.
- Post Categories
- [electronic prior authorization](https://blog.pocp.com/blog/tag/electronic-prior-authorization)
- [prior authorizations](https://blog.pocp.com/blog/tag/prior-authorizations)
- [Medication Adherence](https://blog.pocp.com/blog/tag/medication-adherence)
- [Healthcare AI](https://blog.pocp.com/blog/tag/healthcare-ai)
- [eMedication Management](https://blog.pocp.com/blog/tag/emedication-management)
- [Artificial Intelligence](https://blog.pocp.com/blog/tag/artificial-intelligence)
# POCP Blog
---
Search
- There are no suggestions because the search field is empty.
### RECENT POSTS
### CATEGORIES
- [Interoperability (39)](https://blog.pocp.com/blog/tag/interoperability)
- [Health IT Policy (38)](https://blog.pocp.com/blog/tag/health-it-policy)
- [CMS (28)](https://blog.pocp.com/blog/tag/cms)
- [EHR (24)](https://blog.pocp.com/blog/tag/ehr)
- [FHIR (24)](https://blog.pocp.com/blog/tag/fhir)
- [Health IT Trends (20)](https://blog.pocp.com/blog/tag/health-it-trends)
- [ePrescribing (19)](https://blog.pocp.com/blog/tag/eprescribing)
- [Prior Authorization (16)](https://blog.pocp.com/blog/tag/prior-authorization)
- [Real-Time Benefit Check (15)](https://blog.pocp.com/blog/tag/real-time-benefit-check)
- [Real-Time Pharmacy Benefit Check (15)](https://blog.pocp.com/blog/tag/real-time-pharmacy-benefit-check)
- [Regulatory Trends (15)](https://blog.pocp.com/blog/tag/regulatory-trends)
- [APIs (13)](https://blog.pocp.com/blog/tag/apis)
- [Artificial Intelligence (12)](https://blog.pocp.com/blog/tag/artificial-intelligence)
- [electronic prior authorization (12)](https://blog.pocp.com/blog/tag/electronic-prior-authorization)
- [health IT (12)](https://blog.pocp.com/blog/tag/health-it)
- [Life Sciences (10)](https://blog.pocp.com/blog/tag/life-sciences)
- [NCPDP (10)](https://blog.pocp.com/blog/tag/ncpdp)
- [Policy (10)](https://blog.pocp.com/blog/tag/policy)
- [electronic health records (9)](https://blog.pocp.com/blog/tag/electronic-health-records)
- [pharmacy interoperability (9)](https://blog.pocp.com/blog/tag/pharmacy-interoperability)
- [ASTP (8)](https://blog.pocp.com/blog/tag/astp)
- [CMS NPRM (8)](https://blog.pocp.com/blog/tag/cms-nprm)
- [health information exchange (8)](https://blog.pocp.com/blog/tag/health-information-exchange)
- [HL7 (7)](https://blog.pocp.com/blog/tag/hl7)
- [Payer (7)](https://blog.pocp.com/blog/tag/payer)
- [Specialty Pharmacy (7)](https://blog.pocp.com/blog/tag/specialty-pharmacy)
- [Standards Development (7)](https://blog.pocp.com/blog/tag/standards-development)
- [TEFCA (7)](https://blog.pocp.com/blog/tag/tefca)
- [Value-Based Care (7)](https://blog.pocp.com/blog/tag/value-based-care)
- [e-Prescribing (7)](https://blog.pocp.com/blog/tag/e-prescribing)
- [electronic prescribing (7)](https://blog.pocp.com/blog/tag/electronic-prescribing)
- [Da Vinci Project (6)](https://blog.pocp.com/blog/tag/da-vinci-project)
- [HTI-2 (6)](https://blog.pocp.com/blog/tag/hti-2)
- [ONC (6)](https://blog.pocp.com/blog/tag/onc)
- [Strategy and Research (6)](https://blog.pocp.com/blog/tag/strategy-and-research)
- [healthcare reform (6)](https://blog.pocp.com/blog/tag/healthcare-reform)
- [21st Century Cures Act (5)](https://blog.pocp.com/blog/tag/21st-century-cures-act)
- [Consent (5)](https://blog.pocp.com/blog/tag/consent)
- [EPCS (5)](https://blog.pocp.com/blog/tag/epcs)
- [Federal Healthcare Policy (5)](https://blog.pocp.com/blog/tag/federal-healthcare-policy)
- [HHS (5)](https://blog.pocp.com/blog/tag/hhs)
- [Information Blocking (5)](https://blog.pocp.com/blog/tag/information-blocking)
- [NCPDP SCRIPT (5)](https://blog.pocp.com/blog/tag/ncpdp-script)
- [Patient Data (5)](https://blog.pocp.com/blog/tag/patient-data)
- [Payer Interoperability (5)](https://blog.pocp.com/blog/tag/payer-interoperability)
- [Pharmacy (5)](https://blog.pocp.com/blog/tag/pharmacy)
- [health equity (5)](https://blog.pocp.com/blog/tag/health-equity)
- [pharmaceutical marketing (5)](https://blog.pocp.com/blog/tag/pharmaceutical-marketing)
- [population health (5)](https://blog.pocp.com/blog/tag/population-health)
- [Clinical Decision Support (4)](https://blog.pocp.com/blog/tag/cds)
- [Digital Health Programs (4)](https://blog.pocp.com/blog/tag/digital-health-programs)
- [Digital Therapeutics (4)](https://blog.pocp.com/blog/tag/digital-therapeutics)
- [EHR Dashboard (4)](https://blog.pocp.com/blog/tag/ehr-dashboard)
- [EHR Usability (4)](https://blog.pocp.com/blog/tag/ehr-usability)
- [HIE (4)](https://blog.pocp.com/blog/tag/hie)
- [Health Plans (4)](https://blog.pocp.com/blog/tag/health-plans)
- [Health Technology Solutions (4)](https://blog.pocp.com/blog/tag/health-technology-solutions)
- [Meaningful Use (4)](https://blog.pocp.com/blog/tag/meaningful-use)
- [PDMP (4)](https://blog.pocp.com/blog/tag/pdmp)
- [Pharmacy Benefit Management (4)](https://blog.pocp.com/blog/tag/pharmacy-benefit-management)
- [Strategic roadmap (4)](https://blog.pocp.com/blog/tag/strategic-roadmap)
- [burden reduction (4)](https://blog.pocp.com/blog/tag/burden-reduction)
- [ePrior Authorization (4)](https://blog.pocp.com/blog/tag/eprior-authorization)
- [healthcare regulations (4)](https://blog.pocp.com/blog/tag/healthcare-regulations)
- [pharmacy advance practice (4)](https://blog.pocp.com/blog/tag/pharmacy-advance-practice)
- [price transparency (4)](https://blog.pocp.com/blog/tag/price-transparency)
- [COVID-19 (3)](https://blog.pocp.com/blog/tag/covid-19)
- [Clinical Calculators (3)](https://blog.pocp.com/blog/tag/clinical-calculators)
- [Data Governance (3)](https://blog.pocp.com/blog/tag/data-governance)
- [Diabetes Care (3)](https://blog.pocp.com/blog/tag/diabetes-care)
- [Digital Health (3)](https://blog.pocp.com/blog/tag/digital-health)
- [Drug price transparency (3)](https://blog.pocp.com/blog/tag/drug-price-transparency)
- [EHR Reports (3)](https://blog.pocp.com/blog/tag/ehr-reports)
- [HIMSS (3)](https://blog.pocp.com/blog/tag/himss)
- [Healthcare AI (3)](https://blog.pocp.com/blog/tag/healthcare-ai)
- [Implementation (3)](https://blog.pocp.com/blog/tag/implementation)
- [Innovation (3)](https://blog.pocp.com/blog/tag/innovation)
- [Medication Therapy Management (3)](https://blog.pocp.com/blog/tag/mtm)
- [National Patient Identifier (3)](https://blog.pocp.com/blog/tag/national-patient-identifier)
- [Patient Safety (3)](https://blog.pocp.com/blog/tag/patient-safety)
- [Pharmacy Benefit (3)](https://blog.pocp.com/blog/tag/pharmacy-benefit)
- [Request for Information (3)](https://blog.pocp.com/blog/tag/request-for-information)
- [Speed to Therapy (3)](https://blog.pocp.com/blog/tag/speed-to-therapy)
- [state prescribing laws (3)](https://blog.pocp.com/blog/tag/state-prescribing-laws)
- [Administrative Burden (2)](https://blog.pocp.com/blog/tag/administrative-burden)
- [CDC (2)](https://blog.pocp.com/blog/tag/cdc)
- [Centers for Disease Control (2)](https://blog.pocp.com/blog/tag/centers-for-disease-control)
- [Controlled Substances (2)](https://blog.pocp.com/blog/tag/controlled-substances)
- [Data Efficiency (2)](https://blog.pocp.com/blog/tag/data-efficiency)
- [EHR Certification (2)](https://blog.pocp.com/blog/tag/ehr-certification)
- [EHR Guides (2)](https://blog.pocp.com/blog/tag/ehr-guides)
- [EHRs (2)](https://blog.pocp.com/blog/tag/ehrs)
- [Epic (2)](https://blog.pocp.com/blog/tag/epic)
- [Formulary and Benefit (2)](https://blog.pocp.com/blog/tag/formulary-and-benefit)
- [H.R. 6 (2)](https://blog.pocp.com/blog/tag/h-r-6)
- [Market Assessment (2)](https://blog.pocp.com/blog/tag/market-assessment)
- [Medical Benefit (2)](https://blog.pocp.com/blog/tag/medical-benefit)
- [Medical Pharmacy Benefit Integration (2)](https://blog.pocp.com/blog/tag/medical-pharmacy-benefit-integration)
- [Medicare Payment Reform (2)](https://blog.pocp.com/blog/tag/medicare-payment-reform)
- [Medication Adherence (2)](https://blog.pocp.com/blog/tag/medication-adherence)
- [Member Data (2)](https://blog.pocp.com/blog/tag/member-data)
- [NCPDP Telecommunications Standard Version F6 (2)](https://blog.pocp.com/blog/tag/ncpdp-telecommunications-standard-version-f6)
- [ONC Physician Burden Reduction (2)](https://blog.pocp.com/blog/tag/onc-physician-burden-reduction)
- [Opioid prescribing laws (2)](https://blog.pocp.com/blog/tag/opioid-prescribing-laws)
- [PGx (2)](https://blog.pocp.com/blog/tag/pgx)
- [Part D (2)](https://blog.pocp.com/blog/tag/part-d)
- [Patient Record Sharing (2)](https://blog.pocp.com/blog/tag/patient-record-sharing)
- [Pharmaceutical Manufacturers (2)](https://blog.pocp.com/blog/tag/pharmaceutical-manufacturers)
- [Policy monitoring (2)](https://blog.pocp.com/blog/tag/policy-monitoring)
- [Pre-approval Information Exchange (2)](https://blog.pocp.com/blog/tag/pre-approval-information-exchange)
- [Precision Medicine (2)](https://blog.pocp.com/blog/tag/precision-medicine)
- [REMS (2)](https://blog.pocp.com/blog/tag/rems)
- [Regulatory landscape (2)](https://blog.pocp.com/blog/tag/regulatory-landscape)
- [Specialty Pharmacy Automation (2)](https://blog.pocp.com/blog/tag/specialty-pharmacy-automation)
- [Specialty ePrescribing (2)](https://blog.pocp.com/blog/tag/specialty-eprescribing)
- [Speed to Medication Therapy (2)](https://blog.pocp.com/blog/tag/speed-to-medication-therapy)
- [Telehealth (2)](https://blog.pocp.com/blog/tag/telehealth)
- [Telemedicine (2)](https://blog.pocp.com/blog/tag/telemedicine)
- [care coordination (2)](https://blog.pocp.com/blog/tag/care-coordination)
- [compliance (2)](https://blog.pocp.com/blog/tag/compliance)
- [ePA (2)](https://blog.pocp.com/blog/tag/epa)
- [eRx (2)](https://blog.pocp.com/blog/tag/erx)
- [health dashboards (2)](https://blog.pocp.com/blog/tag/health-dashboards)
- [medication management (2)](https://blog.pocp.com/blog/tag/medication-management)
- [opioid abuse (2)](https://blog.pocp.com/blog/tag/opioid-abuse)
- [patient access (2)](https://blog.pocp.com/blog/tag/patient-access)
- [pharmacist (2)](https://blog.pocp.com/blog/tag/pharmacist)
- [pharmacy business model (2)](https://blog.pocp.com/blog/tag/pharmacy-business-model)
- [prior authorizations (2)](https://blog.pocp.com/blog/tag/prior-authorizations)
- [wearables (2)](https://blog.pocp.com/blog/tag/wearables)
- [ACO (1)](https://blog.pocp.com/blog/tag/aco)
- [AI Policy (1)](https://blog.pocp.com/blog/tag/ai-policy)
- [Antikickback Statutes Reform (1)](https://blog.pocp.com/blog/tag/antikickback-statutes-reform)
- [Biologics and Biosimilars Naming (1)](https://blog.pocp.com/blog/tag/biologics-and-biosimilars-naming)
- [Biosimilars (1)](https://blog.pocp.com/blog/tag/biosimilars)
- [Business Process (1)](https://blog.pocp.com/blog/tag/business-process)
- [CAQH Phase V Operating Rules (1)](https://blog.pocp.com/blog/tag/caqh-phase-v-operating-rules)
- [CARIN Alliance (1)](https://blog.pocp.com/blog/tag/carin-alliance)
- [CDS Hooks (1)](https://blog.pocp.com/blog/tag/cds-hooks)
- [CMS Attachments Rule (1)](https://blog.pocp.com/blog/tag/cms-attachments-rule)
- [CMS-0062P (1)](https://blog.pocp.com/blog/tag/cms-0062p)
- [CRD (1)](https://blog.pocp.com/blog/tag/crd)
- [Canada Biosimilars Naming (1)](https://blog.pocp.com/blog/tag/canada-biosimilars-naming)
- [Canadian ePrescribing (1)](https://blog.pocp.com/blog/tag/canadian-eprescribing)
- [Chronic Disease (1)](https://blog.pocp.com/blog/tag/chronic-disease)
- [Clinical Quality Language (CQL) (1)](https://blog.pocp.com/blog/tag/clinical-quality-language-cql)
- [CodeX (1)](https://blog.pocp.com/blog/tag/codex)
- [CoverMyMeds (1)](https://blog.pocp.com/blog/tag/covermymeds)
- [DSMO (1)](https://blog.pocp.com/blog/tag/dsmo)
- [DTR (1)](https://blog.pocp.com/blog/tag/dtr)
- [DTx (1)](https://blog.pocp.com/blog/tag/dtx)
- [Data Modernization Initiative (1)](https://blog.pocp.com/blog/tag/data-modernization-initiative)
- [Data quality (1)](https://blog.pocp.com/blog/tag/data-quality)
- [Designated Standards Maintenance Organizations (1)](https://blog.pocp.com/blog/tag/designated-standards-maintenance-organizations)
- [Digital Therapeutics Opportunities (1)](https://blog.pocp.com/blog/tag/digital-therapeutics-opportunities)
- [Digital Therapeutics Outlook (1)](https://blog.pocp.com/blog/tag/digital-therapeutics-outlook)
- [Discover Alliance (1)](https://blog.pocp.com/blog/tag/discover-alliance)
- [Drug Launch (1)](https://blog.pocp.com/blog/tag/drug-launch)
- [Drug Manufacturers (1)](https://blog.pocp.com/blog/tag/drug-manufacturers)
- [Drug PA (1)](https://blog.pocp.com/blog/tag/drug-pa)
- [Drug abuse (1)](https://blog.pocp.com/blog/tag/drug-abuse)
- [EHR Apps (1)](https://blog.pocp.com/blog/tag/ehr-apps)
- [Enforcement (1)](https://blog.pocp.com/blog/tag/enforcement)
- [FDA (1)](https://blog.pocp.com/blog/tag/fda)
- [FQHC (1)](https://blog.pocp.com/blog/tag/fqhc)
- [Federally Qualified Health Centers (1)](https://blog.pocp.com/blog/tag/federally-qualified-health-centers)
- [Fee-for-service (1)](https://blog.pocp.com/blog/tag/fee-for-service)
- [Gold-carding (1)](https://blog.pocp.com/blog/tag/gold-carding)
- [HIN (1)](https://blog.pocp.com/blog/tag/hin)
- [HIPAA (1)](https://blog.pocp.com/blog/tag/hipaa)
- [HIT Leaders (1)](https://blog.pocp.com/blog/tag/hit-leaders)
- [HTI-4 (1)](https://blog.pocp.com/blog/tag/hti-4)
- [Health and Human Services (1)](https://blog.pocp.com/blog/tag/health-and-human-services)
- [Health data (1)](https://blog.pocp.com/blog/tag/health-data)
- [Health system (1)](https://blog.pocp.com/blog/tag/health-system)
- [Healthcare artificial intelligence trends (1)](https://blog.pocp.com/blog/tag/healthcare-artificial-intelligence-trends)
- [Human Services (1)](https://blog.pocp.com/blog/tag/human-services)
- [Hypertension (1)](https://blog.pocp.com/blog/tag/hypertension)
- [I-STOP (1)](https://blog.pocp.com/blog/tag/i-stop)
- [Insurance (1)](https://blog.pocp.com/blog/tag/insurance)
- [Landscape analysis (1)](https://blog.pocp.com/blog/tag/landscape-analysis)
- [MACRA (1)](https://blog.pocp.com/blog/tag/macra)
- [MIPS (1)](https://blog.pocp.com/blog/tag/mips)
- [Market Intelligence (1)](https://blog.pocp.com/blog/tag/market-intelligence)
- [Market Research (1)](https://blog.pocp.com/blog/tag/market-research)
- [Medication Therapy Management (1)](https://blog.pocp.com/blog/tag/medication-therapy-management)
- [Modernizing Part D CMS-4180-P (1)](https://blog.pocp.com/blog/tag/modernizing-part-d-cms-4180-p)
- [NCPDP F&B (1)](https://blog.pocp.com/blog/tag/ncpdp-fb)
- [NCPDP SCRIPT 2017071 (1)](https://blog.pocp.com/blog/tag/ncpdp-script-2017071)
- [NCPDP Workgroups (1)](https://blog.pocp.com/blog/tag/ncpdp-workgroups)
- [NCQA (1)](https://blog.pocp.com/blog/tag/ncqa)
- [NPI (1)](https://blog.pocp.com/blog/tag/npi)
- [Objective Analysis (1)](https://blog.pocp.com/blog/tag/objective-analysis)
- [Outcomes (1)](https://blog.pocp.com/blog/tag/outcomes)
- [P2 FHIR Taskforce (1)](https://blog.pocp.com/blog/tag/p2-fhir-taskforce)
- [PAS (1)](https://blog.pocp.com/blog/tag/pas)
- [PBMs (1)](https://blog.pocp.com/blog/tag/pbms)
- [PIE (1)](https://blog.pocp.com/blog/tag/pie)
- [POCP News (1)](https://blog.pocp.com/blog/tag/pocp-news)
- [Pain Management (1)](https://blog.pocp.com/blog/tag/pain-management)
- [Pharmacogenomics (1)](https://blog.pocp.com/blog/tag/pharmacogenomics)
- [Population Health Management (1)](https://blog.pocp.com/blog/tag/population-health-management)
- [Prescribing Authority (1)](https://blog.pocp.com/blog/tag/prescribing-authority)
- [Prescribing signatures (1)](https://blog.pocp.com/blog/tag/prescribing-signatures)
- [Prescription Price Transparency (1)](https://blog.pocp.com/blog/tag/prescription-price-transparency)
- [Prescription affordability (1)](https://blog.pocp.com/blog/tag/prescription-affordability)
- [Prescription drug benefit (1)](https://blog.pocp.com/blog/tag/prescription-drug-benefit)
- [Prescription pricing (1)](https://blog.pocp.com/blog/tag/prescription-pricing)
- [Public Health (1)](https://blog.pocp.com/blog/tag/public-health)
- [Quality Measures (1)](https://blog.pocp.com/blog/tag/quality-measures)
- [Quality Reporting (1)](https://blog.pocp.com/blog/tag/quality-reporting)
- [RTBT (1)](https://blog.pocp.com/blog/tag/rtbt)
- [RTPB (1)](https://blog.pocp.com/blog/tag/rtpb)
- [Regulatory overhead (1)](https://blog.pocp.com/blog/tag/regulatory-overhead)
- [RelayHealth (1)](https://blog.pocp.com/blog/tag/relayhealth)
- [Rx renewal (1)](https://blog.pocp.com/blog/tag/rx-renewal)
- [RxBC (1)](https://blog.pocp.com/blog/tag/rxbc)
- [Sandbox (1)](https://blog.pocp.com/blog/tag/sandbox)
- [Social Determinants of Health (1)](https://blog.pocp.com/blog/tag/social-determinants-of-health)
- [Specialty Pharmacy Enrollment (1)](https://blog.pocp.com/blog/tag/specialty-pharmacy-enrollment)
- [Specialty medication (1)](https://blog.pocp.com/blog/tag/specialty-medication)
- [Stark Anti-Kickback Statute (1)](https://blog.pocp.com/blog/tag/stark-anti-kickback-statute)
- [Stark Law Reform (1)](https://blog.pocp.com/blog/tag/stark-law-reform)
- [State policy (1)](https://blog.pocp.com/blog/tag/state-policy)
- [Surescripts (1)](https://blog.pocp.com/blog/tag/surescripts)
- [Telecommunications (1)](https://blog.pocp.com/blog/tag/telecommunications)
- [Telehealth / Telemedicine (1)](https://blog.pocp.com/blog/tag/telehealth-telemedicine)
- [U.S. Senate Special Committee on Aging (1)](https://blog.pocp.com/blog/tag/u-s-senate-special-committee-on-aging)
- [Uncategorized (1)](https://blog.pocp.com/blog/tag/uncategorized)
- [Virtual Visits (1)](https://blog.pocp.com/blog/tag/virtual-visits)
- [Working from home (1)](https://blog.pocp.com/blog/tag/working-from-home)
- [X12 (1)](https://blog.pocp.com/blog/tag/x12)
- [blockchain (1)](https://blog.pocp.com/blog/tag/blockchain)
- [care gaps (1)](https://blog.pocp.com/blog/tag/care-gaps)
- [community pharmacy (1)](https://blog.pocp.com/blog/tag/community-pharmacy)
- [consumerism (1)](https://blog.pocp.com/blog/tag/consumerism)
- [data platforms (1)](https://blog.pocp.com/blog/tag/data-platforms)
- [digiceuticals (1)](https://blog.pocp.com/blog/tag/digiceuticals)
- [digital health platforms (1)](https://blog.pocp.com/blog/tag/digital-health-platforms)
- [eConsent (1)](https://blog.pocp.com/blog/tag/econsent)
- [eMedication Management (1)](https://blog.pocp.com/blog/tag/emedication-management)
- [healthcare (1)](https://blog.pocp.com/blog/tag/healthcare)
- [home health (1)](https://blog.pocp.com/blog/tag/home-health)
- [machine learning (1)](https://blog.pocp.com/blog/tag/machine-learning)
- [medical deserts (1)](https://blog.pocp.com/blog/tag/medical-deserts)
- [patient generated data (1)](https://blog.pocp.com/blog/tag/patient-generated-data)
- [payers (1)](https://blog.pocp.com/blog/tag/payers)
- [payment model (1)](https://blog.pocp.com/blog/tag/payment-model)
- [prescription drug monitoring programs (1)](https://blog.pocp.com/blog/tag/prescription-drug-monitoring-programs)
- [rural health (1)](https://blog.pocp.com/blog/tag/rural-health)
- [vive (1)](https://blog.pocp.com/blog/tag/vive)
See all
[](https://www.pocp.com)
©2026 Point-of-Care Partners | All Rights Reserved
- [](https://twitter.com/pocpHIT)
- [](http://www.linkedin.com/company/point-of-care-partners)
- [](https://www.pocp.com/pocp-blog/)
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "Michael Solomon",
"url" : "https://blog.pocp.com/blog/author/michael_solomon"
},
"dateModified" : "2020-06-19T15:25:47.623Z",
"datePublished" : "2019-01-31T16:19:16.000Z",
"headline" : "Beyond the AI Hype: Practical Applications to Augment Medication Management Decisions - Part 2",
"image" : [ "https://blog.pocp.com/hubfs/Imported_Blog_Media/iStock-645606376-400x278-1.jpg" ],
"mainEntityOfPage" : {
"@id" : "https://blog.pocp.com/blog/beyond-the-ai-hype-part-2",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.pocp.com/hubfs/pocp-logo-2016.jpg"
},
"name" : "Point-of-Care Partners"
}
}
```